Thiotepa, Etoposide, Cyclophosphamide, ARA-C and Melphalan (TECAM) conditioning protocol for autologous stem cell transplantation - An alternative non BCNU containing regimen

被引:0
|
作者
Grisariu, S. [1 ]
Shapira, M. Y. [1 ]
Or, R. [1 ]
Avni, B. [1 ]
机构
[1] Hadassah Med Ctr, Bone Marrow Transplantat, IL-91120 Jerusalem, Israel
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P613
引用
收藏
页码:S441 / S441
页数:1
相关论文
共 50 条
  • [1] TECAM (thiotepa, etoposide, cyclophosphamide, Ara-c and melphalan) as conditoning regimen for autologous stem cell transplantation in patients with lymphoma
    Patir, P.
    Soyer, N.
    Sahin, F.
    Saydam, G.
    Tobu, M.
    Tombuloglu, M.
    Vural, F.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S336 - S337
  • [2] Thiotepa, Etoposide, Cyclophosphamide, Cytarabine, and Melphalan (TECAM) Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma
    Grisariu, Sigal
    Shapira, Michael Y.
    Or, Reuven
    Avni, Batia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (04): : 272 - 279
  • [3] TECAM (THIOTEPA, ETOPOSIDE, CYCLOPHOSPHAMIDE, ARA-C AND MELPHALAN) AS CONDITONING REGIMEN FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH NON-HODGKIN AND HODGKIN LYMPHOMA
    Patir, P.
    Duran, M.
    Koseoglu, F.
    Uysal, A.
    Sahin, F.
    Tobu, M.
    Saydam, G.
    Vural, F.
    LEUKEMIA RESEARCH, 2016, 49 : S37 - S38
  • [4] THE COMPARISON OF BEEAM (BENDAMUSTINE, ETOPOSIDE, ARA-C AND MELPHALAN) AND BEAM (BCNU, ETOPOSIDE, ARA-C AND MELPHALAN) CONDITIONING REGIMENS IN LYMPHOMA PATIENTS TREATED WITH AUTOLOGOUS STEM CELL TRANSPLANTATION
    Mikhailova, N.
    Kondakova, E.
    Maramy-Zonouzi, N.
    Bondarenko, S.
    Podoltseva, E.
    Medvedeva, N.
    Popova, M.
    Ryabchikova, V.
    Afanasiev, B.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S448 - S449
  • [5] Tecam (Thiotepa, Etoposide, cyclophosphamide, Cytarabine and Melphalan) Is an Effective and Safe Conditioning Regimen for Autologous Transplant in Lymphoma
    Cohen, Yarden
    Lebel, Eyal
    Zimran, Eran
    Shaulov, Adir
    Stepensky, Polina
    Greenzaid, Sigal Grisariu
    Avni, Batia
    BLOOD, 2022, 140 : 4859 - 4860
  • [6] TEAM (thiotepa, etoposide, cytarabine, melphalan) as conditioning regimen for lymphoma treatment with autologous haematopoietic stem cell transplantation
    Carella, A. M.
    Palumbo, G.
    Greco, M.
    Merla, E.
    Dell'Olio, M.
    Scalzulli, P.
    Capalbo, S.
    Pisapia, G.
    Mazza, P.
    Ferrara, F.
    Guarini, A.
    Iacobazzi, A.
    Musto, P.
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S214 - S214
  • [7] TEAM (Thiotepa, Etoposide, Cytarabine, Melphalan) as conditioning regimen for lymphoma treatment with autologous haematopoietic stem cell transplantation
    Carella, A. M.
    Palumbo, G.
    Greco, M. M.
    Merla, E.
    Dell'Olio, M.
    Pisapia, G.
    Mazza, P.
    Ferrara, F.
    Musto, P.
    Rana, A.
    Guarini, A.
    Di Tonno, P.
    Pastore, D.
    D'Elia, M.
    Specchia, G.
    Capalbo, S.
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S248 - S248
  • [8] TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) AS CONDITIONING REGIMEN FOR LYMPHOMA TREATMENT WITH AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION
    Carella, A. M.
    Palumbo, G.
    Merla, E.
    Ferrara, F.
    Greco, M.
    Dell'Olio, M.
    Scalzulli, P.
    Pisapia, G.
    Mazza, P.
    Guarini, A.
    Iacobazzi, A.
    Musto, P.
    Capalbo, S.
    Cascavilla, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 66 - 66
  • [9] LACE (lomustine, ara-C, cyclophosphamide and etoposide): An effective conditioning regimen for autologous and allogeneic transplantation with minimal toxicity.
    Orchard, K
    Giles, C
    Apperley, J
    Goldman, JM
    Kanfer, EJ
    Samson, D
    BLOOD, 1997, 90 (10) : 1855 - 1855
  • [10] TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) AS CONDITIONING REGIMEN FOR LYMPHOMA TREATMENT WITH AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT)
    Carella, A. M.
    Palumbo, G.
    Merla, E.
    Greco, M.
    Fontana, A.
    Specchia, G.
    Pisapia, G.
    Mazza, P.
    Guarini, A.
    Rana, A.
    Ditonno, P.
    Ferrara, F.
    Musto, P.
    Pastore, D.
    Scime, R.
    Pellegrini, F.
    Capalbo, S.
    Cavallaro, A. Maria
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S177 - S177